obesity drug news today glp-1 october 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford How to Invest in GLP-1

For decades, we've known that excess body weight is a major risk factor for at least 13 types of cancer

Alcohol doesnt really adjust to that new setup

Will all dosage strengths of Ozempic and Wegovy be available immediately after the shortage ends

These medications have been shown to not only support weight loss but also help manage blood sugar levels, addressing two common struggles that often feel impossible to tackle simultaneously

Knowing about side effects up front is one of the best ways to manage them well, says Chatham

Market expansion is being driven by the increasing prevalence of obesity, diabetes, and other metabolic disorders, growing health awareness, improving healthcare infrastructure, and greater availability of advanced treatment options